/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
CitiusTech Wins the 2019 Innovators Award for the Best Value-Based Care Solution
BI-Clinical RMM has been awarded for its ability to empower
healthcare organizations with the flexibility to build, edit and deploy
complex quality measures. It also includes the healthcare industry’s
largest library of 900+ pre-built clinical quality measures and KPIs.
PRINCETON, N.J.–(BUSINESS WIRE)–CitiusTech,
a leading provider of healthcare technology services and solutions,
today received the 2019
Innovators Award in the Value-Based Care category for its BI-Clinical
RMM (BIC-RMM) solution. For more than a decade, Healthcare
Innovation has honored those on the forefront of healthcare IT
innovation with its Innovators Awards.
As the industry continues the transition towards value-based care, there
is an increasing need for organizations to measure and report clinical
quality metrics. One of the key challenges facing providers and payers
today is tracking hundreds of these complex and ever-changing clinical
quality measures (CQMs) and KPIs. BIC-RMM enables healthcare
organizations to build, edit and manage multiple rule types – CQMs,
alerts, cohorts – with an easy-to-use, do-it-yourself interface without
any dependency on IT/technical teams.
“Regulatory requirements are overwhelming in themselves, but additional
contractual and value-based payments are forcing payers and providers to
extend their quality strategy,” says Jeffrey Springer, SVP of Healthcare
Solutions at CitiusTech. “With BIC-RMM, healthcare organizations now
have the ability to build a comprehensive quality strategy with the
flexibility to manage all of their quality rules through a unified
solution.”
BIC-RMM has been adopted by several large health systems and leading
health plans to manage their quality initiatives and lower turnaround
time for building and deploying quality measures by up to 40 percent and
improve efficiency by up to 60 percent. By leveraging the BIC-RMM
solution, these organizations are better positioned to drive their
quality initiatives and value-based care programs.
A core strength of BIC-RMM is its ability to support major regulatory
programs including NCQA and CMS. It also simplifies rules management by
providing 900+ pre-built CQMs and KPIs (including MIPS / MACRA, HEDIS®,
QCDR) as well as custom quality measures.
*HEDIS is a registered trademark of the National Committee for Quality
Assurance (NCQA).
About CitiusTech
CitiusTech (www.citiustech.com)
is a specialist provider of healthcare technology services and solutions
to medical technology companies, providers, payers and life sciences
organizations, with over 3,500 professionals worldwide. CitiusTech’s
services and solutions include healthcare software development,
healthcare interoperability, regulatory compliance, BI/analytics,
consumer engagement, care coordination and population health management.
CitiusTech helps customers accelerate innovation in healthcare through
solutions and accelerators for clinical quality reporting, healthcare
big data, cloud computing, mobile health and predictive analytics. With
cutting-edge technology expertise, world-class service quality and a
global resource base, CitiusTech consistently delivers best-in-class
solutions and an unmatched cost advantage to healthcare clients
worldwide.
Contacts
Priyal Shah
CitiusTech
[email protected]
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Humboldt
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
Apollo Green to distribute Humboldt Seed Company clonal cannabis genetics to Germany, Portugal and Australia
SAN FRANCISCO, April 30, 2024 /PRNewswire/ — Humboldt Seed Company (HSC), California’s leading cannabis seed producer, has announced a partnership with Canadian-based Apollo Green to make eight breeder cuts available to researchers, licensed commercial cultivators and home growers in legal markets worldwide. This first-to-market clonal genetics release is a significant milestone and will expand access to distinctive, high-quality cannabis genetics in both established and emerging global markets including Germany, Portugal and Australia.
The curated, breeder-verified selection includes pioneering triploid genetics, such as OG Triploid and Donutz Triploid alongside the legendary cult classic Blueberry Muffin. Also available are All Gas OG with a THC content of 21% and four high-THC strains in the 30-35% range: Golden Sands, Guzzlerz, Jelly Donutz and Orange Creampop. These selections represent the top .01% from HSC’s extensive California pheno-hunting program.
Exports will begin in May under Apollo Green’s Canadian federal cannabis license. All shipments have Canadian phytosanitary certification, ensuring plants have been inspected, and are clean and free of pests.
“Access for all to quality genetics has been our core focus since the beginning,” said HSC Co-founder and Chief Science Officer, Benjamin Lind. “Our science-based approach to breeding aligns perfectly with Apollo Green’s high standards and we are excited to be able to extend these hand-selected cuts to a wider audience, especially at this pivotal time where we’re seeing positive regulatory changes globally.”
Oisin Tierney, Apollo Green Director of Business Development, said, “California has long been recognized for setting industry standards, and we are proud to play a role in bringing these esteemed genetics to cultivators worldwide. The triploids are especially noteworthy in terms of the unprecedented potential for enhanced plant vigor, higher yields, shorter flowering times and superior returns for solventless extraction.”
About Humboldt Seed Company
Established in 2001, Humboldt Seed Company is a Northern California heritage brand providing quality cannabis genetics to commercial cultivators and home growers in legalized states across the U.S. and international markets including Spain, Canada, Jamaica, South Africa, Colombia, France, Portugal, Greece, the UK, Malta and Thailand. With a focus on environmental and social justice, they combine traditional breeding and modern scientific practices in their strain development program. They have served the cannabis community for over two decades.
For more information visit https://humboldtseedcompany.com/.
About Apollo Green
Licensed since 2019, Apollo Green is Canada’s leader in cannabis genetics. The company’s mission is to provide an ever-growing bank of seeds and clones to medical patients and recreational consumers. Apollo Green provides clean, trusted cannabis seeds and clones, which are backed by the foremost tissue culture technology to reduce risks, costs and time-to-market for licensed producers around the world. Apollo Green is passionate about cannabis genetics.
For more information visit https://apollogreen.com/.
Media contact
Jaana Prall
[email protected]
Logo – https://mma.prnewswire.com/media/2328955/Humboldt_Seed_Company_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/humboldt-seed-company-partners-with-apollo-green-to-bring-california-cannabis-genetics-to-the-global-marketplace-302131618.html
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
transfer2 weeks ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Innocan1 week ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf1 week ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis1 week ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE1 day ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET